PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
John K. Marshall, MD, MSc, FRCPC, AGAF, CAGF - Targeting IL-23 in Ulcerative Colitis: Can We Raise the Bar in Disease Control for Our Patients?
Visit https://www.peervoice.com/THE860 to view the entire programme with slides. After completing “John K. Marshall, MD, MSc, FRCPC, AGAF, CAGF - Targeting IL-23 in Ulcerative Colitis: Can We Raise the Bar in Disease Control for Our Patients?”, participants will be able to: Explain the mechanism of action of anti-IL-23 therapies in ulcerative colitis (UC); Evaluate the latest clinical evidence with anti-IL-23 agents in UC; Discuss evolving treatment goals and definitions of remission in patients with UC; and Define the potential role of anti-IL-23 agents in patients with UC, based on the latest evidence.